Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC

Fig. 1

Outcome after allo-HCT. Overall survival (a), leukemia-free survival (b), cumulative incidence of relapse (c), cumulative incidence of GVHD-free and relapse-free survival (d), and cumulative incidence of non-relapse mortality (e). OS, overall survival; LFS, leukemia-free survival; RI, relapse incidence, rGRFS, refined GVHD-free relapse-free survival; NRM, non-relapse mortality

Back to article page